Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GDNF Family Receptor Alpha-3 (GFRα3) is a GPI-anchored cell surface receptor and a member of the GDNF receptor family. It binds primarily to artemin (ARTN) and forms a signaling complex with the RET tyrosine kinase receptor, mediating downstream signaling pathways involved in nervous system development, neuron survival, and sensory nerve function. It is also expressed in pancreatic endocrine progenitors and has been implicated in cancer and pain pathways.
GFRα3 forms a signaling complex with the RET tyrosine kinase receptor upon binding to Artemin, mediating artemin-induced autophosphorylation and activation of RET, and initiating downstream pathways like MAPK signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GDNF Family Receptor Alpha-3 (GFRα3).